For in vitro laboratory research only. Not for human or veterinary consumption.
India Warehouse LETROZOLE — 2.5mg per tablet, 100-count pack. Third-generation aromatase inhibitor for postmenopausal hormone receptor-positive breast cancer. Off-label: ovulation induction in PCOS, male hypogonadism from hyperestrogenism. Key warning: Not for premenopausal women without ovarian suppression. Bone density monitoring required — bisphosphonate may be needed. Contraindicated in pregnancy.
Third-generation aromatase inhibitor for postmenopausal hormone receptor-positive breast cancer. Off-label: ovulation induction in PCOS, male hypogonadism from hyperestrogenism.
How it Works
Non-steroidal competitive aromatase inhibitor — more potent than anastrozole. Reduces estrogen by over 99% in postmenopausal women.
Quick Specs
Form
Oral tablets — pre-dosed
Active Ingredient
LETROZOLE
Dose per Tablet
2.5MG
Pack Size
10×10 (100 tablets)
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)
Common Side Effects
Arthralgia/myalgia (very common — major cause of discontinuation), hot flushes, bone loss/fractures, fatigue, headache, hypercholesterolemia.
Safety Warnings
Not for premenopausal women without ovarian suppression. Bone density monitoring required — bisphosphonate may be needed. Contraindicated in pregnancy. International shipping: 7–14 days
Research use only
This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.
